Transcranial Magnetic Stimulation for Parkinson's Disease

This trial explores how a specific brain area affects movement in people with Parkinson's disease during the transition from walking on a special treadmill to regular ground. Researchers will use Transcranial Magnetic Stimulation (TMS) to stimulate the brain and observe any changes in participants' walking patterns. The study compares the effects of real and sham TMS treatments. It seeks participants with Parkinson's disease who can walk independently for 30 minutes and have never used a split-belt treadmill.

As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance understanding and treatment of Parkinson's disease.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that transcranial magnetic stimulation (TMS) is generally safe for people with Parkinson's disease. In past studies, the risk of side effects, such as headaches, was low—about 4 out of 100 people experienced one. Importantly, no seizures were reported. Most side effects, like headaches, were mild and resolved on their own. Overall, TMS is considered well-tolerated, with a strong safety record in Parkinson's patients.¹²³⁴⁵

Researchers are excited about transcranial magnetic stimulation (TMS) for Parkinson's Disease because it offers a non-invasive approach that targets the brain directly. Unlike traditional treatments like levodopa or dopamine agonists, which are medications, TMS uses magnetic fields to stimulate specific brain areas, potentially reducing symptoms without the need for drugs. This technique could minimize side effects associated with long-term medication use. Additionally, by alternating between active TMS and sham TMS, researchers can better understand its effectiveness, paving the way for new insights into managing Parkinson's symptoms.

This trial will compare the effects of active repetitive transcranial magnetic stimulation (rTMS) with sham rTMS in individuals with Parkinson's disease. Studies have shown that rTMS can improve movement in people with Parkinson's disease. Research indicates that targeting specific brain areas with rTMS can enhance movement and might also aid thinking skills. Data from various studies suggest that rTMS is more effective than no treatment. Additionally, rTMS is considered safe, with only a few side effects reported. Overall, strong evidence supports rTMS in addressing movement problems in Parkinson's disease.²⁶⁷⁸⁹